Dazukibart, an anti–interferon beta monoclonal antibody, showed potential in reducing dermatomyositis symptoms, with ...

The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because ...

Among patients treated with isotretinoin for acne, approximately one fifth experienced a relapse that required additional treatment with systemic medication, and 8.2% underwent a retrial with ...